Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lagarde

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medical Genetics|August 1, 1997
Assessment of French patients with LPL deficiency for French Canadian mutationsL Foubert, J L De Gennes, J P Lagarde, et al.
Bulletin Du Cancer|January 1, 1990
[Pure ovarian dysgerminoma. Evaluation of experiences and definition of a therapeutic strategy]J M Dilhuydy, P Lagarde, J Chauvergne, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Activating mutations of the calcium-sensing receptor: management of hypocalcemiaA Lienhardt, M Bai, J P Lagarde, et al.
Revue De Laryngologie - Otologie - Rhinologie|June 18, 1999
[Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence?]G Dolivet, P Colosetti, J L Merlin, et al.
Atherosclerosis|January 16, 1998
Familial defective apolipoprotein B-100 in hypercholesterolemic Chinese Canadians: identification of a unique haplotype of the apolipoprotein B-100 alleleL O Abdel-Wareth, S N Pimstone, J P Lagarde, et al.
British Journal of Cancer|November 1, 1992
Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trialsA Ravaud, N B Bui, J M Coindre, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defectM L Kottler, S Chauvin, N Lahlou, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemiaA Lienhardt, M Garabédian, M Bai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1992
Results of postoperative radiation therapy in medullary carcinoma of the thyroid: a retrospective study by the French Federation of Cancer Institutes--the Radiotherapy Cooperative GroupT D Nguyen, J L Chassard, P Lagarde, et al.
Vision Research|April 22, 1999
Exclusion of the apoE gene in autosomal dominant retinitis pigmentosaE H Souied, P Benlian, J M Rozet, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medical Genetics|August 1, 1997
Assessment of French patients with LPL deficiency for French Canadian mutationsL Foubert, J L De Gennes, J P Lagarde, et al.
Bulletin Du Cancer|January 1, 1990
[Pure ovarian dysgerminoma. Evaluation of experiences and definition of a therapeutic strategy]J M Dilhuydy, P Lagarde, J Chauvergne, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Activating mutations of the calcium-sensing receptor: management of hypocalcemiaA Lienhardt, M Bai, J P Lagarde, et al.
Revue De Laryngologie - Otologie - Rhinologie|June 18, 1999
[Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence?]G Dolivet, P Colosetti, J L Merlin, et al.
Atherosclerosis|January 16, 1998
Familial defective apolipoprotein B-100 in hypercholesterolemic Chinese Canadians: identification of a unique haplotype of the apolipoprotein B-100 alleleL O Abdel-Wareth, S N Pimstone, J P Lagarde, et al.
British Journal of Cancer|November 1, 1992
Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trialsA Ravaud, N B Bui, J M Coindre, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defectM L Kottler, S Chauvin, N Lahlou, et al.
The Journal of Clinical Endocrinology and Metabolism|April 19, 2000
A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemiaA Lienhardt, M Garabédian, M Bai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1992
Results of postoperative radiation therapy in medullary carcinoma of the thyroid: a retrospective study by the French Federation of Cancer Institutes--the Radiotherapy Cooperative GroupT D Nguyen, J L Chassard, P Lagarde, et al.
Vision Research|April 22, 1999
Exclusion of the apoE gene in autosomal dominant retinitis pigmentosaE H Souied, P Benlian, J M Rozet, et al.
Pageof 8